Acadian Asset Management’s Aligos Therapeutics ALGS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28K | Buy |
+3,913
| New | +$28K | ﹤0.01% | 1548 |
|
|
2024
Q4 | – | Sell |
-30,597
| Closed | -$263K | – | 1604 |
|
|
2024
Q3 | $263K | Sell |
30,597
-2,582
| -8% | -$22.2K | ﹤0.01% | 1276 |
|
|
2024
Q2 | $289K | Buy |
33,179
+6,859
| +26% | +$59.7K | ﹤0.01% | 1347 |
|
|
2024
Q1 | $644K | Buy |
26,320
+3,945
| +18% | +$96.5K | ﹤0.01% | 947 |
|
|
2023
Q4 | $370K | Sell |
22,375
-214
| -0.9% | -$3.54K | ﹤0.01% | 1099 |
|
|
2023
Q3 | $420K | Hold |
22,589
| – | – | ﹤0.01% | 1046 |
|
|
2023
Q2 | $547K | Hold |
22,589
| – | – | ﹤0.01% | 1035 |
|
|
2023
Q1 | $492K | Buy |
22,589
+9,201
| +69% | +$200K | ﹤0.01% | 1054 |
|
|
2022
Q4 | $318K | Hold |
13,388
| – | – | ﹤0.01% | 1164 |
|
|
2022
Q3 | $366K | Buy |
13,388
+815
| +6% | +$22.3K | ﹤0.01% | 1069 |
|
|
2022
Q2 | $380K | Buy |
12,573
+5,544
| +79% | +$168K | ﹤0.01% | 1051 |
|
|
2022
Q1 | $377K | Buy |
+7,029
| New | +$377K | ﹤0.01% | 1068 |
|